Repligen Corp (RGEN) Stock Price

RGENStock

$181.69+45.54%52W

Market Cap$10.25B

P/E192.87x

PEG Ratio2.41

Div yield—

Beta1.10

RGEN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)20.26%

Price vs S&P 500 (4W)21.91%

PEG Ratio2.41

VGM Score52.77

P/E Ratio (Annual)192.87x

P/CF (Annual)80.31x

Book Value / Share (Quarterly)$37.43

P/TBV (Annual)5.36x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-2.70%

Cash Flow / Share (Quarterly)$1.95

Price vs S&P 500 (YTD)-1.12%

Gross Margin (TTM)53.84%

Net Profit Margin (TTM)5.29%

EPS (TTM)$0.73

10-Day Avg Trading Volume1.04M

EPS Excl Extra (TTM)$0.73

Revenue Growth (5Y)15.05%

EPS (Annual)$0.86

ROI (Annual)1.85%

Gross Margin (Annual)52.65%

Net Profit Margin (5Y Avg)10.10%

Cash / Share (Quarterly)$14.36

P/E Basic Excl Extra (TTM)227.02x

Revenue Growth QoQ (YoY)11.93%

EPS Growth (5Y)-4.90%

P/E Normalized (Annual)192.87x

ROA (Last FY)1.66%

Revenue Growth TTM (YoY)16.49%

EBITD / Share (TTM)$2.29

ROE (5Y Avg)3.98%

Operating Margin (TTM)6.49%

Cash Flow / Share (Annual)$1.63

P/B Ratio4.46x

P/B Ratio (Quarterly)3.64x

Net Income / Employee (Annual)$24,400

EV / Revenue (TTM)11.94x

Net Interest Coverage (TTM)13.28x

ROA (TTM)1.41%

EPS Growth QoQ (YoY)-66.40%

EV / EBITDA (TTM)72.26x

EPS Incl Extra (Annual)$0.86

Current Ratio (Annual)8.37x

Quick Ratio (Quarterly)7.30x

3-Month Avg Trading Volume1.18M

52-Week Price Return45.54%

EV / Free Cash Flow (Annual)102.24x

P/E Incl Extra (TTM)227.02x

Revenue / Employee (TTM)$392,600

Tangible BV / Share (Quarterly)$31.09

P/S Ratio (Annual)12.77x

Asset Turnover (Annual)0.25x

52-Week High$188.73

Operating Margin (5Y Avg)12.08%

EPS Excl Extra (Annual)$0.86

CapEx CAGR (5Y)-0.44%

Tangible BV CAGR (5Y)6.73%

26-Week Price Return31.50%

Quick Ratio (Annual)7.02x

13-Week Price Return60.20%

Total Debt / Equity (Annual)0.26x

Current Ratio (Quarterly)9.05x

Enterprise Value$9.37B

Revenue / Share Growth (5Y)13.94%

Asset Turnover (TTM)0.27x

Book Value / Share Growth (5Y)6.03%

Revenue / Employee (Annual)$369,100

Inventory Turnover (Annual)2.23x

Pretax Margin (Annual)8.45%

Cash / Share (Annual)$13.63

3-Month Return Std Dev49.85%

Gross Margin (5Y Avg)53.29%

Net Income / Employee (TTM)$20,800

EBITDA CAGR (5Y)9.31%

EBITDA Interim CAGR (5Y)-10.34%

ROE (Last FY)2.32%

Net Interest Coverage (Annual)-3.82x

EPS Basic Excl Extra (Annual)$0.86

P/FCF (TTM)85.61x

Receivables Turnover (TTM)4.99x

EV / Free Cash Flow (TTM)85.10x

Total Debt / Equity (Quarterly)0.26x

EPS Incl Extra (TTM)$0.73

Receivables Turnover (Annual)5.04x

ROI (TTM)1.57%

P/S Ratio (TTM)12.01x

Pretax Margin (5Y Avg)12.66%

Revenue / Share (Annual)$13.05

Tangible BV / Share (Annual)$30.54

Forward P/E60.38x

Free OCF CAGR (5Y)20.36%

Price vs S&P 500 (52W)27.23%

P/E Ratio (TTM)227.02x

Year-to-Date Return10.84%

5-Day Price Return9.31%

EPS Normalized (Annual)$0.86

ROA (5Y Avg)2.97%

Net Profit Margin (Annual)6.62%

Month-to-Date Return28.80%

Cash Flow / Share (TTM)$3.18

EBITD / Share (Annual)$2.37

EPS Growth (3Y)-35.59%

Operating Margin (Annual)7.47%

LT Debt / Equity (Annual)0.26x

P/CF (TTM)69.92x

ROI (5Y Avg)3.42%

P/E Excl Extra (TTM)227.02x

LT Debt / Equity (Quarterly)0.26x

EPS Basic Excl Extra (TTM)$0.73

P/TBV (Quarterly)4.39x

P/B Ratio (Annual)4.38x

Inventory Turnover (TTM)2.12x

Pretax Margin (TTM)6.64%

Book Value / Share (Annual)$37.39

Price vs S&P 500 (13W)57.41%

Net Margin Growth (5Y)-16.54%

Beta1.10x

P/FCF (Annual)102.85x

Revenue / Share (TTM)$13.86

ROE (TTM)1.98%

52-Week Low$100.99

vGradeD

gGradeC

mGradeA

vgmGradeC

RGEN Earnings Surprise History

Q2 250.37est. 0.39

Q3 250.46est. 0.41

Q4 250.49est. 0.44

Q1 260.48est. 0.39

Q2 260.54est. 0.45

RGEN Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.07

4.11

Industry Peers — Biological Products(183)

Symbol	Value Score	Growth Score	Momentum Score	Price
RGENRepligen Corp	D	C	A	$181.69
AMGNAmgen Inc	C	C	B	$442.24
GILDGilead Sciences Inc	C	B	B	$148.77
MRNAModerna, Inc. Common Stock	D	C	A	$158.83
ARGXargenx SE American Depositary Shares	D	A	B	$1019.49
RVMDRevolution Medicines, Inc. Common Stock	F	—	A	$211.38
BIIBBiogen Inc. Common Stock	C	D	B	$220.77
BNTXBioNTech SE American Depositary Share	C	C	B	$114.05
NBIXNeurocrine Biosciences Inc	C	B	C	$153.37
EXELExelixis Inc	C	B	B	$56.72
HALOHalozyme Therapeutics, Inc.	C	B	A	$109.32
TECHBio-Techne Corp.	D	C	B	$72.33
KRYSKrystal Biotech, Inc. Common Stock	D	B	B	$356.19
KYMRKymera Therapeutics, Inc. Common Stock	D	B	B	$126.64
APGEApogee Therapeutics, Inc. Common Stock	—	—	A	$134.85
TWSTTwist Bioscience Corporation Common Stock	D	B	A	$151.42
PCVXVaxcyte, Inc. Common Stock	—	—	B	$61.09
QGENQIAGEN N.V.	C	C	C	$43.65
IMVTImmunovant, Inc. Common Stock	—	—	B	$43.50
IBRXImmunityBio, Inc. Common Stock	F	A	C	$8.19
SRRKScholar Rock Holding Corporation Common Stock	F	—	B	$58.25
CGONCG Oncology, Inc. Common stock	F	A	A	$78.95
CRSPCRISPR Therapeutics AG	D	B	B	$60.90
RLAYRelay Therapeutics, Inc. Common Stock	F	D	A	$20.57
ADPTAdaptive Biotechnologies Corporation Common Stock	D	B	A	$26.25
DNLIDenali Therapeutics Inc. Common Stock	F	—	B	$24.93
IOVAIovance Biotherapeutics, Inc. Common Stock	C	B	A	$8.44
BEAMBeam Therapeutics Inc. Common Stock	C	B	B	$31.03
TARSTarsus Pharmaceuticals, Inc. Common Stock	D	A	B	$71.45
BCRXBioCryst Pharmaceuticals Inc	B	A	B	$9.83
KODKodiak Sciences Inc Common Stock	—	—	B	$39.46
COAGHemab Therapeutics Holdings, Inc. Common Stock	—	—	B	$49.65
MESOMesoblast Limited American Depositary Shares	D	B	C	$17.19
VCELVericel Corporation	D	B	C	$43.22
ADMAADMA Biologics, Inc.	C	C	C	$9.72
TSHATaysha Gene Therapies, Inc. Common Stock	F	B	B	$6.20
IMCRImmunocore Holdings plc American Depositary Shares	D	B	B	$37.40
RXRXRecursion Pharmaceuticals, Inc. Class A Common Stock	D	C	C	$3.56
VIRVir Biotechnology, Inc. Common Stock	B	B	B	$10.71
INBXInhibrx Biosciences, Inc. Common Stock	D	C	B	$122.72
ALVOAlvotech Ordinary Shares	C	D	B	$5.05
MAZEMaze Therapeutics, Inc. Common Stock	—	—	B	$30.42
NVAXNovavax Inc	B	D	C	$9.44
REPLReplimune Group, Inc.	—	—	A	$15.80
SLBTSL Science Holding Limited Ordinary Shares	—	—	F	$2.64
MGTXMeiraGTx Holdings plc Ordinary Shares	D	C	A	$14.92
VORVor Biopharma Inc. Common Stock	—	—	B	$24.01
CGEMCullinan Therapeutics, Inc. Common Stock	—	—	A	$22.95
IMTXImmatics N.V. Ordinary Shares	C	D	C	$9.24
ODTXOdyssey Therapeutics, Inc. Common Stock	—	C	A	$26.23
GLUEMonte Rosa Therapeutics, Inc. Common Stock	D	F	C	$14.56

About Repligen Corp

Repligen develops and sells bioprocessing equipment and supplies for manufacturing biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. The company serves biopharmaceutical companies and contract manufacturers globally with four core product categories: filtration and fluid management (55% of revenue), chromatography (21%), proteins (11%), and process analytics (13%). Revenue is geographically balanced across North America (44%), Europe (37%), and Asia Pacific (19%).